%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-08-06T18:17:32+03:00
2013-08-06T18:17:32+03:00
2013-08-06T18:17:32+03:00
application/pdf
bs-9901R-Biotin
uuid:4e5c6152-efcd-4e64-9240-b7ec9b15d57f
uuid:6131e199-7595-4c51-ba0e-ab71dac5be52
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[30 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.443 574.5 -732.504 re
f
BT
0.2 scn
/TT0 1 Tf
6.6111 0 0 6.6111 21.2388 767.1818 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw T*
[(800.501.7654)-34( )1([DOMESTIC])]TJ
0 -1.5 TD
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
140.8153076 0 0 -79.3325653 443.6847076 810.153656 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 9.2555 0 0 9.2555 21.2388 715.6157 Tm
[(bs)-67(-)-69(9901R)-12(-)-69(Biotin)]TJ
/TT0 1 Tf
-0.04 Tw 7.2722 0 0 7.2722 28.5109 669.3383 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -2.091 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(The)-59( platelet)-17( activating)-27( factor)-4( \(PAF\))-17( acetylhydrolases)-16( catalyze)-3( hydrolysis)-4( of)-48( the)-36( sn)-87(-)-1(2)-90( ester)-81( bond)-66( of)-48( PAF)-55( and related)]TJ
0 -1.455 TD
[(pro)-89(-)-1(inflammatory)-19( phospholipids)-7( and thus)-13( attenuate)-53( their)-84( bioactivity.)-82( The)-59( family)-88( of)-48( PAF)-55( acetylhydrolases)-16( includes)]TJ
0 -1.455 TD
[(one)-9( secreted)-86( plasma)-64( isozyme)-19( and two)-17( intracellular)-59( isozymes.)-89( The)-59( intracellular)-59( isozymes)-28( are)-43( distinguished)-46( by)]TJ
T*
[(differences)-88( in)-31( their)-84( primary)-90( sequence,)-88( tissue)-6( localization,)-30( subunit)-37( composition)-85( and substrate)-9( preferences.)-82( The)]TJ
0 -1.455 TD
[(most)-19( thoroughly)-84( characterized)-47( intracellular)-59( isoform,)-54( PAFAH1B,)-69( is)-52( a)-20( heterotrimeric)-87( protein)-79( expressed)-23( in)-31( brain)]TJ
T*
[(tissue)-6( and plays)-22( and important)-88( role)-69( in)-31( brain)-48( development)-41( and function.)-47( PAFAH1B)-9( is)-52( comprised)-34( of)-48( a)-20( regulatory)]TJ
0 -1.455 TD
[(subunit)-37( \(LIS1\))-78( and two)-17( homologous)-8( \(63%)-2( identity\))-83( catalytic)-40( subunits)-45( \(PAFAH1B2)-80( and PAFAH1B3\),)-50( which)-88( harbor)]TJ
0 -1.455 TD
[(all)-17( the)-37( activity)-74( of)-48( the)-37( enzyme.)-32( The)-59( PAFAH1B2)-8( and PAFAH1B3)-8( subunits)-45( readily)-80( associate)-56( with)-46( very)-27( high)-11( affinity)-82( to)]TJ
0 -1.455 TD
[(form)-30( heterodimers,)-78( and this)-69( dimerization)-85( is)-52( essential)-90( for)-52( both)-12( stability)-77( and catalytic)-40( activity.)-43( PAFAH1B3)-8( is)-52( also)]TJ
/C2_0 1 Tf
0 Tw 0 -1.455 TD
[<004600520050005000520051004F005C>-33<0003>40<004E00510052005A0051>-10<0003>40<00440056>-29<0003>40<0033002400290024002B00140025>-9<0003>40<0015001C004E00270044>-25<0003>40<00560058004500580051004C0057000F>-6<0003>40<0033002400290024002B00140025>-9<0003>40<00560058004500580051004C0057>-37<0003>40<00520055>-6<0003>40<0033002400290024002B00140025>-9<0003>40<00560058004500580051004C0057>-37<0003>40<012E00140011>]TJ
/TT1 1 Tf
0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
0 Tw -6.727 -2 Td
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Prepared)-46( as)-29( lyophilized)-45( powder)-87( and shipped)-36( on)-81( ice.)-26( Store)-44( at)-50( -)-1(20\260C)-18( for)-52( one)-9( year)-91( as)-29( lyophilized)-45( powder)-87( or)-6( liquid.)]TJ
0 -1.455 TD
[(Please)-15( reconstitute)-64( before)-83( use.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-36( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-37( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-36( package.)]TJ
/TT1 1 Tf
0 Tw 54.182 34.182 Td
(Size:)Tj
/TT0 1 Tf
-0.04 Tw 3 -0.091 Td
[(100ul)-29( or)-6( 100ug)-69( lyophilized)]TJ
/TT1 1 Tf
0 Tw -3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.6111 0 0 6.6111 422.5294 623.7221 Tm
(Human,Mouse,Rat,Dog,Pig,Cow,Horse,Rabbit,Sheep,)Tj
0 scn
/TT1 1 Tf
7.2722 0 0 7.2722 422.5294 609.8389 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 432.4459 592.3196 cm
0 0 m
0 1.322 -1.983 1.322 -1.983 0 c
-1.983 -1.322 0 -1.322 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.2722 0 0 7.2722 439.057 590.6669 Tm
[(WB\(1:100)-42(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 432.4459 581.7419 cm
0 0 m
0 1.322 -1.983 1.322 -1.983 0 c
-1.983 -1.322 0 -1.322 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.2722 0 0 7.2722 439.057 580.0892 Tm
[(ELISA\(1:500)-35(-)-1(1000\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 432.4459 571.1643 cm
0 0 m
0 1.322 -1.983 1.322 -1.983 0 c
-1.983 -1.322 0 -1.322 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.2722 0 0 7.2722 439.057 569.5115 Tm
[(IHC)-78(-)-1(P\(1:100)-73(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 432.4459 560.5866 cm
0 0 m
0 1.322 -1.983 1.322 -1.983 0 c
-1.983 -1.322 0 -1.322 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.2722 0 0 7.2722 439.057 558.9338 Tm
[(IHC)-78(-)-1(F\(1:100)-13(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 432.4459 550.0089 cm
0 0 m
0 1.322 -1.983 1.322 -1.983 0 c
-1.983 -1.322 0 -1.322 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 7.2722 0 0 7.2722 439.057 548.3562 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)]TJ
0 -1.455 TD
[(Optimal)-36( working)-62( dilutions)-48( must)-4( be)]TJ
T*
[(determined)-86( by)-40( the)-36( end)-90( user.)]TJ
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.6111 0 0 6.6111 465.5012 484.8901 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 7.2722 0 0 7.2722 422.5294 471.0069 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.6111 0 0 6.6111 501.2008 471.0069 Tm
(26kDa)Tj
0 scn
/TT1 1 Tf
7.2722 0 0 7.2722 422.5294 457.1237 Tm
(Preservatives:)Tj
0.2 scn
/TT0 1 Tf
-0.012 Tw 6.6111 0 0 6.6111 486.6565 457.1237 Tm
[(10ug/uL)-59( )1(BSA)-54( )1(and)-64( )1(0.1%)-28( )1(NaN3.)]TJ
0 scn
0.021 Tw 5.9499 0 0 5.9499 422.5294 430.0184 Tm
[(For)-20( )1(research)-16( )1(use)-26( )1(only.)-91( )1(CAUTION:)-12( )1(Not)-11( )1(for)-1( )1(human)-72( )1(or)]TJ
0 -1.333 TD
[(animal)-94( )1(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
561.9390106 0 0 -0.6611023 18.5943604 707.0213165 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.5777 0 0 10.5777 21.2388 84.9218 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 19.2555 691.8159 cm
0 0 m
0 1.763 -2.644 1.763 -2.644 0 c
-2.644 -1.763 0 -1.763 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/TT1 1 Tf
-0.007 Tw 9.2555 0 0 9.2555 28.5109 689.1715 Tm
[(Rabbit)-50( Anti)-28(-)-69(PAFAH1B3/PAFAHG)-45( Polyclonal)-4( Antibody,)-47( Biotin)-37( conjugated)]TJ
/CS0 cs 0 scn
/TT0 1 Tf
0 Tw 10.5777 0 0 10.5777 25.2054 376.4689 Tm
( )Tj
12.062 0 Td
( )Tj
12.125 0 Td
( )Tj
-24.187 -2.25 Td
( )Tj
12.062 0 Td
( )Tj
12.125 0 Td
( )Tj
-24.187 -2.25 Td
( )Tj
12.062 0 Td
( )Tj
12.125 0 Td
( )Tj
-0.04 Tw 7.2722 0 0 7.2722 26.5276 297.1364 Tm
[(For)-30( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.6111 0 0 6.6111 179.9039 297.1364 Tm
(HERE)Tj
/CS0 cs 0 scn
7.2722 0 0 7.2722 196.4315 297.1364 Tm
(.)Tj
ET
q
/GS0 gs
0.6611023 0 0 -594.9942474 408.6461639 706.3601837 cm
/Im2 Do
Q
q
/GS0 gs
5.9499359 0 0 -40.3273926 578.5500793 123.2658234 cm
/Im3 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
(Hs3wM)
endobj
26 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L